@article{Demir_İçaçan_Yakar_Doğukan_2020, title={The effect of paricalcitol on Hepatitis B immunization in hemodialysis patients: The effect of paricalcitol on Hepatitis B immunization}, volume={7}, url={https://medscidiscovery.com/index.php/msd/article/view/393}, DOI={10.36472/msd.v7i7.393}, abstractNote={<p><strong>Objective:</strong> Hepatitis B virus (HBV) infection has high morbidity and mortality. Therefore vaccination for HBV is crucial, especially for risk groups. In this study, we aimed to determine the effect of paricalcitol on HBV immunization in maintenance hemodialysis (HD) patients.</p> <p><strong>Methods:</strong> Forty-two maintenance HD patients enrolled in the study. Group 1 was the control group who didn’t receive paricalcitol treatment (n:28, control group). Group 2 was the paricalcitol treatment group for secondary hyperparathyroidism (n:14, paricalcitol group). Anti-HBs titers were measured with a three-month interval for two times.</p> <p><strong>Results:</strong> The mean age of the patients in Group 1 was 58.50(18-80) years, while of the patients in Group 2 was 46.50 (23-81) years. There was no statistically significant difference between the groups in terms of age and gender (p = 0.200, p = 0.508, respectively). Baseline anti-HBs titer in the control group was 190.32 IU/L (20.18-1000), and 187.89 IU/L (38.77-1000) in the paricalcitol treated group. After 3 months of follow-up, anti-HBs titers decreased to 114.72 IU/L (13.68-1000) from 190.32 IU/L (20.18-1000) in the control group and to the 175.27 IU/L (14.25-1000) from 187.89 IU/L (38.77-1000) in the paricalcitol group. The decrease in anti-HBs titers was significant in the control group, whereas it was not significant in the paricalcitol group (P = 0.001, 0.209, respectively).</p> <p><strong>Conclusion:</strong> The protective effect of paricalcitol on hepatitis B seroconversion in HD patients was observed. We think that paricalcitol may be used as an adjuvant for hepatitis B seroconversion.</p>}, number={7}, journal={Medical Science and Discovery}, author={Demir, Mustafa and İçaçan, Gamze and Yakar, Burkay and Doğukan, Ayhan}, year={2020}, month={Jul.}, pages={549–553} }